Montville, NJ, June 21, 2001 -- Berlex Laboratories, Inc., a U.S. affiliate of Schering AG, Germany (NYSE:SHR), announced today that YASMIN (R)(drospirenone and ethinyl estradiol), a new, low-dose, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback